GM1 ganglioside ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
6パーキンソン病1

6. パーキンソン病


臨床試験数 : 2,307 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00037830
(ClinicalTrials.gov)
November 199922/5/2002GM1 Ganglioside Effects on Parkinson's DiseaseThe Study of GM1 Ganglioside, A Potential New Parkinson's Disease MedicationParkinson DiseaseDrug: GM1 ganglioside;Drug: PlaceboThomas Jefferson UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Completed39 Years85 YearsAll94Phase 2United States